A/Prof Jyotsna Batra named Cure Cancer Australia's Researcher of the Year 2018
“By analysing the DNA of around 50,000 individuals, half of which belongs to prostate cancer patients, we’ve identified 100 genetic variations associated with prostate cancer risk”, she says. “They can collectively explain about 30% of the inherited component of the disease.”
Jyotsna’s research focusses on how gene sequences, when used in conjunction with the traditional Prostate-Specific Antigen blood test, can be used to identify men predisposed to prostate cancer.
"I am extremely grateful to Cure Cancer Australia for this award,” said Jyotsna. “This funding has given me the freedom to carry out novel and advanced research, which wouldn’t have been possible otherwise.”
Jyotsna has received three previous Grants from CCA, which helped establish her lab and undertake some innovative research.
This recognition will further her prostate cancer research as she makes the transition from an early career researcher to the mid-career phase. This Award will also enable Jyotsna to attend an international Conference to disseminate her research findings to broader audience. Read more on the Cure Cancer Australia website.
